
This product is made from peptide analogs of modified erythropoietin, without significant erythropoietic activity.
ARA-290 (cibinetide) is used to reduce inflammation and support nerve repair without affecting red blood cell production.
Clinically, it is applied in neuropathic pain conditions such as diabetic and small fiber neuropathy to improve nerve function and reduce pain.
It also has immunomodulatory effects that may benefit autoimmune and chronic inflammatory diseases, with additional interest in supporting endothelial and metabolic health in diabetic patients.
Neuroprotection.
Reduced Systemic Inflammation.
Chronic Pain Reduction.
Nerve Regeneration Support.
Improved Endothelial Function.
Reduced Oxidative Stress.
Improved Diabetic Neuropathy Symptoms.
Tissue Repair Activation.
$13500 MXN, $794 USD (Price per box of 3 vials)
Mechanism of action: Anti-inflammatory and neuroprotective effect.
Clinical applications: Diabetic neuropathy, chronic pain, autoimmune diseases, and systemic inflammation.
Therapeutic category: Nootropic.
Route of administration: Subcutaneous (SC) and
Intravenous (IV).
Dosage: 4 mg.
Frequency of application: 1-2x per week.
Administration: Subcutaneous injection (Download Guide)
© Copyright 2026. Vallarta Vitality. All Rights Reserved | Terms & Conditions | Privacy Policy